MAIDA, Ivana
 Distribuzione geografica
Continente #
NA - Nord America 9.149
EU - Europa 5.470
AS - Asia 5.380
SA - Sud America 2.920
Continente sconosciuto - Info sul continente non disponibili 345
AF - Africa 218
OC - Oceania 17
Totale 23.499
Nazione #
US - Stati Uniti d'America 8.940
BR - Brasile 2.573
IT - Italia 2.223
SG - Singapore 2.160
CN - Cina 1.592
UA - Ucraina 944
FR - Francia 622
HK - Hong Kong 517
DE - Germania 479
VN - Vietnam 397
SE - Svezia 271
FI - Finlandia 194
GB - Regno Unito 143
AR - Argentina 121
NL - Olanda 114
IE - Irlanda 100
BD - Bangladesh 89
RU - Federazione Russa 78
TR - Turchia 78
CA - Canada 76
IN - India 72
IQ - Iraq 64
MX - Messico 64
ZA - Sudafrica 61
EC - Ecuador 60
ES - Italia 48
PL - Polonia 46
PK - Pakistan 45
CZ - Repubblica Ceca 42
JP - Giappone 40
MA - Marocco 40
UZ - Uzbekistan 37
KR - Corea 34
VE - Venezuela 33
CO - Colombia 32
ID - Indonesia 30
PY - Paraguay 30
AZ - Azerbaigian 27
BE - Belgio 27
AT - Austria 24
AE - Emirati Arabi Uniti 23
KE - Kenya 23
TN - Tunisia 23
CH - Svizzera 22
CL - Cile 22
UY - Uruguay 20
IR - Iran 19
PE - Perù 19
DZ - Algeria 18
KZ - Kazakistan 18
AU - Australia 17
EG - Egitto 17
IL - Israele 13
JO - Giordania 13
LB - Libano 12
LT - Lituania 12
NP - Nepal 12
PA - Panama 12
SA - Arabia Saudita 12
CR - Costa Rica 11
EU - Europa 11
AL - Albania 10
PH - Filippine 10
PS - Palestinian Territory 10
RS - Serbia 10
DO - Repubblica Dominicana 9
JM - Giamaica 9
SN - Senegal 9
BO - Bolivia 8
HU - Ungheria 8
GA - Gabon 7
HN - Honduras 7
NI - Nicaragua 7
OM - Oman 7
BG - Bulgaria 6
BH - Bahrain 6
BY - Bielorussia 6
GE - Georgia 6
KG - Kirghizistan 6
KW - Kuwait 6
NG - Nigeria 6
QA - Qatar 6
BA - Bosnia-Erzegovina 4
ET - Etiopia 4
GR - Grecia 4
MD - Moldavia 4
MK - Macedonia 4
RO - Romania 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
GT - Guatemala 3
PT - Portogallo 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AM - Armenia 2
BB - Barbados 2
BN - Brunei Darussalam 2
CY - Cipro 2
Totale 23.133
Città #
Dallas 2.614
Singapore 1.165
Chandler 913
San Jose 783
Jacksonville 558
Hong Kong 509
Ashburn 426
Beijing 334
Princeton 333
Council Bluffs 274
Nanjing 254
Columbus 214
Dearborn 187
Rome 182
São Paulo 179
Lauterbourg 166
New York 159
Ho Chi Minh City 153
Milan 153
Wilmington 124
Santa Clara 123
Shanghai 111
Boardman 108
Los Angeles 106
Nanchang 103
Sassari 101
Dublin 98
Ann Arbor 97
Hanoi 92
Rio de Janeiro 89
Shenyang 75
Naples 70
Belo Horizonte 67
Tianjin 64
Munich 59
Florence 51
Woodbridge 50
Hebei 48
Changsha 46
Brasília 44
Helsinki 44
Porto Alegre 41
Tokyo 38
Andover 37
Brno 37
Jiaxing 37
Orem 37
Nuremberg 36
Turin 36
Campinas 35
San Francisco 35
Tashkent 35
Jinan 34
Seoul 32
Bologna 31
Hangzhou 31
Toronto 31
Buffalo 30
Curitiba 30
Frankfurt am Main 30
Goiânia 30
Palermo 30
Warsaw 30
Bari 29
Guarulhos 29
Ningbo 28
Brussels 27
Johannesburg 26
Atlanta 25
Baghdad 25
Chicago 25
Montreal 25
Ribeirão Preto 25
Zhengzhou 25
Baku 24
Brooklyn 24
Norwalk 24
Dhaka 23
Kunming 22
Salvador 22
Sorocaba 22
Fortaleza 20
Montevideo 20
Nairobi 20
Turku 20
Verona 19
Guangzhou 18
Haiphong 18
Houston 18
London 18
Phoenix 18
Asunción 17
Buenos Aires 17
Campo Grande 17
Denver 17
Juiz de Fora 17
São José dos Campos 17
Betim 16
Caxias do Sul 16
Guayaquil 16
Totale 12.858
Nome #
CASE REPORT: MIOCARDITE ACUTA DA CITOMEGALOVIRUS IN GIOVANE PAZIENTE IMMUNOCOMPETENTE 2.069
Accertamento diagnostico di meningoencefalite da Listeria monocytogenes mediante PCR in soggetti immunocompetenti 292
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 284
Analisi dell'attività dei C.I.O. in ambito regionale e proposta di un modello organizzativo - funzionale 237
Analisi del case-mix ospedaliero. Il controllo dei ricoveri outlier 229
Strategie di sorveglianza attiva e networking per il controllo delle infezioni da L. monocytogenes 221
Activation of the potentially neuropathogenic HERV-W/MSRV-type endogenous retroviruses during severe infectious mononucleosis and past Epstein-Barr virus infection: the missing link with multiple sclerosis? 216
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome 204
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 198
Approccio molecolare nello studio di un episodio infettivo ospedaliero da Pseudomonas aeruginosa 189
Andamento della parotite epidemica nell’Azienda USL n.1 di Sassari e considerazioni sulle strategie vaccinali 186
Aspetti epidemiologici di infezioni gastroenteriche in paesi in via di sviluppo 185
Aspetti epidemiologici sulla colonizzazione da Streptococcus agalactiae nelle donne in gravidanza. 184
Antibiotic resistant H-pylori are extremely common in Sardinia. 181
alpha-and gamma-tocophetol modulate the apoptotic signaling induced by oxidized low-density lipoprotein in human coronaric smooth muscle cells 181
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 177
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 176
Approccio molecolare nella diagnosi della tubercolosi umana 175
Associazione sierologia tra HIV e Trichomonas vaginalis nella popolazione femminile del Nord-Sardegna. 168
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 167
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 166
Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C 160
Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. 158
Genotypic characterization of clarithromycin-resistant Helicobacter pylori strains 151
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 149
QuantiFERON TB Gold: a new method for latent tuberculosis infection 148
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 147
Higher Risk of Hyperglycemia in HIV-Infected Patients Treated with Didanosine Plus Tenofovir 146
Andamento delle infezioni nosocomiali nel complesso chirurgico Università- Azienda USL n. 1- Sassari. 146
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era 144
Caratteristiche cliniche e risposta alla terapia anti-HCV nei soggetti HIV-HCV coinfetti con livelli persistentemente normali di ALT 142
Clonal relationships among Salmonella enteritidis phage type 3 outbreak isolates traced by DNA fingerprinting 141
Utilizzo della metodologia bayesiana per lo studio della variazione geografica del rischio in epidemiologia. 140
PREVENTION OF TRAVEL ASSOCIATED INFECTION DUE TO LEGIONELLA: MICROBIOLOGIC ANALYSIS IN LINERS AND CRUISE SHIPS 140
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 140
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin 140
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution 140
Comparison of 2D Shear Wave Elastography and Transient Elastography in Non-Invasive Evaluation of Liver Fibrosis in Hepatitis C Virus-Related Chronic Liver Disease 139
Valutazione della qualità delle schede di dimissione ospedaliera 137
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 136
Neurocognitive performance and cardiovascular risk in a cohort of HIV-infected patients 134
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. 133
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 131
Inquinamento ambientale nelle sale operatorie. Nota II: condizioni microclimatiche e microbiologiche 131
Occurrence of infections during combination treatment with interferons and ribavirin for chronic hepatitis C: Role of neutropenia and of interferon pegylation 131
Pulmonary Involvement in Recurrent Respiratory Papillomatosis: A Systematic Review 129
Rapid detection and identification of Mycobacterium tuberculosis by Real Time PCR and Bactec 960 MIGT 129
Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes 128
First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcome 126
Listeria monocytogenes meningoencephalitis: molecular methods for diagnosis and for monitoring the response to chemotherapy 125
Visceral Leishmaniasis and Pegylated Interferon. Author’s reply 125
Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus 125
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 125
Safety and efficacy of direct-acting antivirals in transfusion-dependent thalassemic patients with chronic hepatitis C 124
Characterization of resistance profiles in HCV 2-3-4 DAA-naive and DAA-experienced infected patients in Italy 124
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? 123
Cytopenias during treatment of HIV-HCV-coinfection with pegylated interferon and ribavirin: safety analysis of the OPERA study. 122
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 122
Joint replacement for avascular necrosis in people living with HIV 122
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? 122
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience 121
Monitoraggio di metalli pesanti nelle acque costiere della Sardegna settentrionale mediante utilizzo di indicatori biologici 121
Epidemiology of Salmonellosis in Sardinia, Italy: 1995-2001 121
HIV related aneurisms 121
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 120
OPERA: use of pegylated interferon plus ribavirin for treating hepatitis C/HIV co-infection in interferon-naive patients. 118
Epidemiologia e prevenzione delle infezioni da Micobatteri su base molecolare 117
Genetic determinants in critical domains of NS5A are associated with genotype 1b HCV-induced hepatocellular carcinoma 117
Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience 117
Hepatitis C virus-RNAclearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin 117
Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV-Infected Patients 116
Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir. 116
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes 115
Database per il monitoraggio del rischio professionale negli operatori sanitari 113
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 113
Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations 112
Modulation by α- and γ-tochopherol and oxidized low density lipoprotein in human coronaric smooth muscle cells 112
Surveillance of Poliomyelitis in Italy: immunity status of population against polio and environmental circulation of Poliovirus. General illustration of the results 112
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression 110
Predictors of Virological Response to Atazanavir in Protease Inhibitor-Experienced Patients 110
Failure of Hepatitis C Therapy in HIV-Coinfected Drug Users Is Not Due to a Shift in Hepatitis C Virus Genotype 110
Serum homocysteine levels are increased in women with gestational diabetes mellitus 110
Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies 110
Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection. 110
Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies 108
Specific Genetic Determinants in NS5A and Core Regions Correlate with Genotype 1b HCV-Induced Hepatocellular Carcinoma: Implications for Viral Markers of Disease Progression 108
Characteristics and Prospects for Hepatitis C Therapy of an HIV-HCV Coinfected Population Followed at a Reference HIV Center 107
Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation 107
Severe liver disease associated with prolonged exposure to antiretroviral drugs 107
Evalutaion and comparison of molecular techniques for epidemiological typing of M. tuberculosis 107
Quick diagnostic approach for HIV/STDs among migrants: results from a monocentric Italian cohort 106
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 106
Very late HCV relapse following triple therapy for hepatitis C. 106
Triple-nucleoside regimens versus efavirenz 106
The changing face of the HIV epidemic in Northern Sardinia: increased diagnoses among pregnant women 106
Simplification From Protease Inhibitors to Once- or Twice-Daily Raltegravir: The ODIS Trial 105
Database per il monitoraggio del rischio professionale negli operatori sanitari 105
Severe portal hypertension in HIV patients with no primary liver disease: prevalence, histology and potential etiology 104
The The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients 104
Hepatitis C Viremia in HIV/HCV-Coinfected Patients: Lower Levels in Presence of Chronic Hepatitis B 103
Totale 15.814
Categoria #
all - tutte 92.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.302


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022813 0 27 24 46 18 19 45 67 77 32 110 348
2022/20231.962 199 101 39 314 190 334 21 222 331 25 108 78
2023/2024930 105 62 32 41 193 96 27 52 16 57 97 152
2024/20255.792 113 161 376 136 197 193 360 1.074 1.964 763 314 141
2025/20268.413 345 1.982 1.231 1.222 735 451 1.168 236 332 387 194 130
2026/2027850 306 544 0 0 0 0 0 0 0 0 0 0
Totale 23.499